Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psoriasis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psoriasis
    Sexual Dysfunction Improves Among Psoriasis Patients Treated With Ustekinumab: Presented at AAD - (DGDispatch)
    Patients With Psoriasis Benefit From Ustekinumab Treatment Up to 3 Years: Presented at AAD - (DGDispatch)
    Etanercept Appears Safe in Paediatric Psoriasis After 96 Weeks: Presented at AAD - (DGDispatch)
    Meta-analysis Reveals Low Infection Rates With Methotrexate in Psoriasis: Presented at AAD - (DGDispatch)
    Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial - (BMJ)

    News archive

     Recent webcasts/CME - Psoriasis
    • Using Biologics to Improve Both Physical and Social Function in Rheumatic Diseases
    • Rheumatic Diseases: Using Anti-TNF-alpha Agents to Improve Everyday Patient Function
    • Treating to Target: Long-Term Safety and Efficacy in Rheumatoid Arthritis
    • Management of Psoriasis: Update for the Pharmacist
      Exploring Psoriatic Arthritis: Bridging Dermatology and Rheumatology

      Webcasts/CME archive

       Recent cases - Psoriasis
        Therapeutic Effect of Hyperbaric Oxygen in Psoriasis Vulgaris: Two Case Reports and a Review of the Literature
        Concomitant Xeroderma Pigmentosum and Disseminated Small Plaque Psoriasis - The First Case of an Antinomic Association: A Case Report
        Extensive Psoriasis Induced by Pegylated Interferon: A Case Report
        Pulmonary Sarcoidosis Associated with Psoriasis Vulgaris: Coincidental Occurrence or Causal Association? Case Report
        Leukemia Cutis Resembling a Flare-Up of Psoriasis

        Cases archive
          




        my personal edition > psoriasis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Optimal Narrowband Ultraviolet B Light Phototherapy for Psoriasis

        A DGReview of :"A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis."
        British Journal of Dermatology

        11/14/2002
        By Robert Short


        Treatment with narrowband ultraviolet B light three times a week clears psoriasis faster than twice a week.

        Dr. H Cameron and colleagues at the Photobiology Unit, Department of Dermatology, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland, studied 113 patients. The researchers had previously established that three times weekly narrowband ultraviolet B light was preferable to five times weekly treatment in their population of psoriasis patients.

        The study was an observer-blinded, randomised comparison of whole-body narrowband ultraviolet B phototherapy on outpatients who attended the clinic. Their objective in the current study of chronic plaque psoriasis was to compare twice-weekly treatment with three times weekly treatment. Treatment continued until clearance or until the fourth treatment after minimal residual activity.

        Forty out of the 58 patients in the twice weekly group reached clearance or minimal residual activity. Forty-four patients out of the 55 patients in the three times weekly group reached clearance or minimal residual activity. It also took 1.5 times longer to reach clearance or minimal residual activity with twice weekly treatment. This amounted to a mean of 88 days rather than 58 days (P<0.0001).

        Dr. Cameron concluded, "Three times weekly narrowband ultraviolet B clears psoriasis significantly faster than twice weekly treatment, and therefore is preferable for most patients."
        Br J Dermatol 2002;147(5):973-8. "A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send